WOBURN, Mass., USA & MARCY L’ETOILE, France--(BUSINESS WIRE)-- Regulatory News: In order to provide faster identification of bloodstream pathogens, bioMérieux (Paris:BIM) has agreed with AdvanDx, Inc. to sign an exclusive distribution agreement for the United States for AdvanDx’s PNA FISH™ rapid diagnostic tests. These tests will be displayed at bioMérieux’s booth from the opening of the American Society of Microbiology (ASM) in Toronto on May 22.
